Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Blueberries Medical Corp C.BBM

Alternate Symbol(s):  BBRRF

Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. Its operations are mainly focused on the Bogota Savannah, in central Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Company’s subsidiaries include Blueberries Research Corporation (BRC) and Blueberries SAS (BBSAS). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.


CSE:BBM - Post by User

Post by Hodo25on Jul 25, 2024 3:13pm
63 Views
Post# 36148585

BBM-CSE SEE BELOW NEWS ON MEDICAL CANNABIS

BBM-CSE SEE BELOW NEWS ON MEDICAL CANNABIS n the cannabis market, Tilray Brands (TSX:TLRYForum) continues to expand its footprint in Europe. Its subsidiary, Tilray Medical, has received approval for its new medical cannabis extract, Tilray Oral Solution THC10, in Portugal. This follows the approval of Tilray Medical’s THC 18 whole flower and the first cannabis extract in Portugal earlier this year. Tilray’s diverse portfolio spans more than 20 brands across more than 20 countries, including renowned names such as Broken Coast, Redecan and Good Supply.
<< Previous
Bullboard Posts
Next >>